SCHEMBL16477282

SCHEMBL16477282

Cc1cc(Cl)c2oc3ccccc3c(=O)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 4/20 0.63
MAOA P21397 10/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.52
GLA P06280 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
PGAM1 P18669 1/20 0.52
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 3/20 0.48
RAB9A P51151 2/20 0.48
LMNA P02545 1/20 0.48
PTGS2 P35354 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
AHR P35869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16477281 0.86 MAPT (0.49) TTRKDM4EALDH1A1CYP3A4MAPT
SCHEMBL29838129 0.84 TTR (0.67) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL31174010 0.84 TTR (0.67) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL5346099 0.84 TTR (0.67) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL7253352 0.84 TTR (0.67) TTRMAOAKDM4EALDH1A1GLA
Xanthone SCHEMBL10615991 0.83 TTR (0.65) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL24403683 0.78 MAOA (0.61) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL6570481 0.78 MAOA (0.64) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL31193433 0.78 MAOA (0.64) TTRMAOAKDM4EALDH1A1GLA
SCHEMBL16477279 0.77 MAPT (0.50) TTRKDM4EALDH1A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9163002-B2 Methodology for the synthesis of xanthones UNIVERSITY OF SOUTH CAROLINA (US) 2015-10-20 US disclosed
US-20140107354-A1 New Methodology for the Synthesis of Xanthones UNIVERSITY OF SOUTH CAROLINA 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107354-A1 New Methodology for the Synthesis of Xanthones XDH, TYR, NISCH TTR 3971/4885MAOA 68/4885KDM4E 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.